
Daniel Bui
Examiner (ID: 8414, Phone: (571)272-2618 , Office: P/2912 )
| Most Active Art Unit | 2912 |
| Art Unit(s) | 2912 |
| Total Applications | 4278 |
| Issued Applications | 4257 |
| Pending Applications | 0 |
| Abandoned Applications | 21 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13672581
[patent_doc_number] => 20160375024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM
[patent_app_type] => utility
[patent_app_number] => 15/039869
[patent_app_country] => US
[patent_app_date] => 2014-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039869 | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM | Nov 24, 2014 | Abandoned |
Array
(
[id] => 10641381
[patent_doc_number] => 09358231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Type II RAF kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/552229
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 53
[patent_no_of_words] => 24015
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552229
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/552229 | Type II RAF kinase inhibitors | Nov 23, 2014 | Issued |
Array
(
[id] => 11090649
[patent_doc_number] => 20160287617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'MYCOTOXIN ABSORBENT AND THE USE THEREOF IN BALANCED FOOD FOR ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/037661
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7467
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037661
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037661 | MYCOTOXIN ABSORBENT AND THE USE THEREOF IN BALANCED FOOD FOR ANIMALS | Nov 20, 2014 | Abandoned |
Array
(
[id] => 11090600
[patent_doc_number] => 20160287568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'COMPOSITION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/038373
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9511
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038373 | COMPOSITION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR | Nov 18, 2014 | Abandoned |
Array
(
[id] => 11066124
[patent_doc_number] => 20160263087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE'
[patent_app_type] => utility
[patent_app_number] => 15/034380
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 56534
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034380
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034380 | NOVEL 4-(INDOL-3-YL)-PYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | Nov 6, 2014 | Abandoned |
Array
(
[id] => 11120586
[patent_doc_number] => 20160317560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'PARTICLES CONTAINING PHOSPHOLIPIDS OR BIOACTIVE FATTY ACIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/035162
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14913
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035162
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035162 | PARTICLES CONTAINING PHOSPHOLIPIDS OR BIOACTIVE FATTY ACIDS AND USES THEREOF | Nov 5, 2014 | Abandoned |
Array
(
[id] => 14323921
[patent_doc_number] => 10292953
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use
[patent_app_type] => utility
[patent_app_number] => 14/511321
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5672
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511321
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511321 | Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use | Oct 9, 2014 | Issued |
Array
(
[id] => 10209323
[patent_doc_number] => 20150094313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF ECTEINASCIDIN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/510819
[patent_app_country] => US
[patent_app_date] => 2014-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12353
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14510819
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/510819 | Pharmaceutical formulations of ecteinascidin compounds | Oct 8, 2014 | Issued |
Array
(
[id] => 11046148
[patent_doc_number] => 20160243106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'SLOW-RELEASE CONJUGATES OF SN-38'
[patent_app_type] => utility
[patent_app_number] => 15/026579
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9935
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026579 | Slow-release conjugates of SN-38 | Oct 2, 2014 | Issued |
Array
(
[id] => 10749776
[patent_doc_number] => 20160095927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Ophthalmic Compositions Containing A Synergistic Combination of Two Polymers'
[patent_app_type] => utility
[patent_app_number] => 14/506598
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4374
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506598 | Ophthalmic Compositions Containing A Synergistic Combination of Two Polymers | Oct 2, 2014 | Abandoned |
Array
(
[id] => 10234445
[patent_doc_number] => 20150119440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/506120
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5128
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506120
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506120 | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof | Oct 2, 2014 | Issued |
Array
(
[id] => 10202692
[patent_doc_number] => 20150087681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'Bendamustine HCL Stable Lyophilized Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/496893
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3783
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14496893
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/496893 | Bendamustine HCL Stable Lyophilized Formulations | Sep 24, 2014 | Abandoned |
Array
(
[id] => 11053262
[patent_doc_number] => 20160250224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'OREXIN-CONTROL OF BONE FORMATION AND LOSS'
[patent_app_type] => utility
[patent_app_number] => 15/024354
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21596
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024354
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024354 | OREXIN-CONTROL OF BONE FORMATION AND LOSS | Sep 23, 2014 | Abandoned |
Array
(
[id] => 10735852
[patent_doc_number] => 20160082002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'METHOD OF REGULATING CARDIAC ARRHYTHMIAS'
[patent_app_type] => utility
[patent_app_number] => 14/494636
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1123
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14494636
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/494636 | METHOD OF REGULATING CARDIAC ARRHYTHMIAS | Sep 23, 2014 | Abandoned |
Array
(
[id] => 10220387
[patent_doc_number] => 20150105380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'METHODS AND USES OF COMPOUNDS FOR TREATING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/493448
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16202
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493448
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/493448 | METHODS AND USES OF COMPOUNDS FOR TREATING DISEASE | Sep 22, 2014 | Abandoned |
Array
(
[id] => 10202690
[patent_doc_number] => 20150087679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'NUTRITIONAL SLEEP SUPPLEMENT'
[patent_app_type] => utility
[patent_app_number] => 14/493228
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2415
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493228
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/493228 | NUTRITIONAL SLEEP SUPPLEMENT | Sep 21, 2014 | Abandoned |
Array
(
[id] => 11032840
[patent_doc_number] => 20160229796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'METFORMIN SALTS TO TREAT TYPE2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 15/022951
[patent_app_country] => US
[patent_app_date] => 2014-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5657
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022951
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022951 | Metformin salts to treat Type2 diabetes | Sep 19, 2014 | Issued |
Array
(
[id] => 11023613
[patent_doc_number] => 20160220568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Antimicrobial Compounds and Methods of Making and Using the Same'
[patent_app_type] => utility
[patent_app_number] => 14/917920
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14473
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917920 | Antimicrobial compounds and methods of making and using the same | Sep 8, 2014 | Issued |
Array
(
[id] => 11002375
[patent_doc_number] => 20160199324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'MULTIPLE MYELOMA TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/912078
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1921
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912078
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912078 | MULTIPLE MYELOMA TREATMENT | Aug 21, 2014 | Abandoned |
Array
(
[id] => 11520476
[patent_doc_number] => 09603857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Inflammatory disease model and method of treatment'
[patent_app_type] => utility
[patent_app_number] => 14/455605
[patent_app_country] => US
[patent_app_date] => 2014-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3647
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14455605
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/455605 | Inflammatory disease model and method of treatment | Aug 7, 2014 | Issued |